Caricamento...
Risperidone versus other atypical antipsychotics for schizophrenia
BACKGROUND: In many countries of the industrialised world second-generation (“atypical”) antipsychotics (SGAs) have become the first line drug treatment for people with schizophrenia. The question as to whether and if so how much the effects of the various SGAs differ is a matter of debate. In this...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4167865/ https://ncbi.nlm.nih.gov/pubmed/21249678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006626.pub2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|